VisCardia
About VisCardia
VisCardia based in Portland, OR is developing a novel implantable device therapy for treating heart failure, a condition that afflicts 10 million patients in the U.S. and Europe.YEAR FOUNDED:
2015
LEADERSHIP:
President and CEO: Peter Bauer Ph.D.
VP, Strategy and Commercialization: Ed Chinchoy Ph.D.
Chairman of the Board: David A. Chazanovitz
3 articles about VisCardia
-
VisCardia Announces Completion of Enrollment and Three Month Follow-Up Visits for Its VisONE® Heart Failure Pilot Study
4/22/2019
VisCardia Inc. announced it has completed enrollment and three month follow-up visits of the company’s VisONE® implantable system pilot for medical refractory heart failure patients with reduced ejection fraction and preserved ventricular synchrony.
-
VisCardia Announces First Implant of the VisONE® System for Treating Heart Failure
8/2/2018
VisCardia Inc. announced today the first implant of the VisONE® implantable system for heart failure, and the commencement of its VisONE Heart Failure pilot study in Ukraine.
-
VisCardia Locks in $12.5 Million, Snags Inovise Medical Assets & Tech
2/3/2017